Submit Deal

IMMUNOMEDICS

Summary

Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 16.78 B

Avg. Deal Size£ 8.39 B

Market Context

Senior Management

Usama Malik
CFO
Darren Opland
Communications Director
Jared Freedberg
General Counsel

Sort

wachtell lipton rosen & katz

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

td cowen

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

sullivan & cromwell

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

goodwin procter

HQ - Boston

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 16.41 B

Total Value

lazard

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

morgan stanley

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

davis polk & wardwell

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

cravath swaine & moore

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

mizuho securities

HQ - Tokyo

financial advisors (1)

1 Shared Deal

1 Opposite

£ 16.41 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy